Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Does anyone think today's news will make up the 21% drubbing AMBS took yesterday?
I did but anyone investing in this company knows they aren't making squat. This wasn't just about the 10Q. This was a classic pump and dump.
Down a healthy 21%. It was close to closing at 7 cents by just a bit! LOL. I guess you can call that filling a gap?
I am not refuting that. What I am talking about are those that sell their snake oil on here.
With what happened today, I think it's going to trade lower. There is NO news what so ever to support any gain. Unless the company releases something tomorrow, but don't bet on it. If you can stomach some losses while you hold and hold for a long period of time, then sure buy. But this stock is very much manipulated. It is why you aren't hearing from those who have pumped this the last week. They have egg all over their faces.
Actually no because of the fact AMBS is on a lesser board and not properly capitalized. If the company ever gets its act together and uplists, that is when we'll know what type of interest there is in the company.
Silence of the lambs on here by those who were pushing this hard. Still think it will hit 7 cents today? ROFL.
Looks like power hour turned into the scorching hour. Thank god I only bought a small amount. I feel sorry for the people who got suckered into buying because of posts touting this. SEriously, people like that should be arrested for fraud and kicked off this board. If Investor's Hub really cared about the integrity of their web site, they'd take my advice.
Lesson for all investors. When people start pumping a stock and telling you how much it is going to be or how it is going to trade like they know inside info, run from them and put them on ignore. Why this site allows these type of posts is beyond me. If you want to use a chart or some means to justify your price claim, then ok but this board has become infested with scam artists. This is why stocks like this crash. This is a typical pump and dump scam.
IF you think this is just profit taking, you are wrong. This is systematic of a very manipulative penny stock being manipulated by people who tell you to buy on here and on other social media sites. These people should be put in jail for fraud.
Just waiting for this to get back to 7 cents as is the claim from the experts on here. They obviously know what they are talking about! LOL.
With the way this is trading, I wouldn't be surprised to see this crash right back to the high 4's low 5's by Friday.
Does anyone know why the July lympro data was not fully presented when it was promised? The PR doesn't state why the full data set wasn't present.
Scientists don't always make good businessmen just like football players don't always make good CEOs.
I am not questioning the science here. I am just questioning the irrational exuberance of many who keep making baseless and untrue claims.
Really? Are you actually saying that every small pre clinical biotech partners before clinical studies? Keep putting the cart before the horse man. Your posts are hysterically inaccurate.
CAN doesn't mean it will. You truly love putting the cart before the horse but you obviously have an agenda here. Fundamentals and facts just don't matter to you. What you are conveniently forgetting is that AMBS wants to use the diagnostic division to fund MANF. In other words, Amarantus doesn't want a partner for MANF.
Now down 17%. But hey, it's going to close at 7 or better as predicted today so no worries! LOL
Seriously, all of you who paint a rosy picture better be buying here. It's a gift since it will be in double digits before we know it.
The day traders are exiting and exiting fast. It's how this stock operates. There is no news coming to warrant any move up. It's why AMBS is a great day trading stock. Now down 12%. What ever buys earlier surely were not enough to stop the onslaught of sells.
And most likely closing near 6 cents.
It's not consolidation though. It's just day traders flipping for easy profit as has been the case with this stock. I would deem consolidation if there was news to warrant a run up. But there was no real news. And considering the hype overdrive in those posting this is going to go parabolic based on hope, is it any wonder the stock is behaving the way it is? Let the company announce a beneficial partnership and then we'll see what real consolidation is.
Nice strength coming in now to wipe out the red. That's a good sign. Let's see how it unfolds.
Indeed it is. Paint it red. Seems to be cooling with some nice buys to counter. Good sign.
If the company can close it at any time, then what is the strategic advantage of delaying it and incurring the extra expense? That's a serious question.
You are right, it does which I missed. My bad. If only others could admit their mistakes on here.
When is Amarantus going to go over .30? It isn't even at 7 cents yet. The PR today doesn't give anything to cheer about because everything is known already based on prior news. Lympro specs still are being tweaked contrary to the CEOs words that we'd know by now how specific it was. The company is no closer to outright owning ESS-W and no word on how the company is going to fund monthly payments to Lonza for extending the option. And the CEO is still vague about what will become of the diagnostics division. In other words, Amarantus investors are still left in the dark by a CEO who makes a lot of false comments.
Btw, notice how this morning's PR says absolutely nothing about uplisting. My bad, it does mention.
And I also took a small speculative stake in the stock.
Get started and tell me how much cash on hand all those companies have and how much they earn vs Mannkind? How many customers do they have vs Mannkind? Let's compare apples to apples.
There are tons of companies that aren't worth their value. Mannkind is one of them. It's not a very hard thing to understand.
Oh, btw. You made my point. Thanks.
That's what message boards are for. MNKD is trading at 200X 2018 earnings per a Motley Fool article I read last week. I'd have no disagreement if MNKD was making some revenue and showing progressive RX numbers week after week but that's not happening. At least not yet. And this isn't even bashing the company but pointing out something that is a fact.
I clearly do and why my point is MNKD is already trading at a hefty multiple as it is. But again, I asked for a logical reason as to why $10 is the magic number and you can't clearly give me a rational answer. That's my point.
Thanks but I never asked for a rehash of why Afrezza or the company has been the target of Wall street or the non believers. I asked for rational reasoning as to why the stock is cheap and deserves a $10 pps. One would use fundamentals to provide that instead of what you just gave me which deflects from the fact that MNKD, with 409,000,000 shares outstanding, no revenue to speak of, slower than anticipated adoption by Endos, no significant growth in prescriptions after almost 4 months on the market, is now valued at almost 2 billion dollars. Again, is a company making no money and showing no real growth (I agree it is still early) in scripts valued fairly at 1.96 billion dollars? And yet you and other probably think a proper valuation is 4.09 billion with NO REVENUES to speak of. If you think that is a fair value at this stage than you truly don't care about or truly understand stock fundamentals.
And to be clear, I do think Afrezza is a game changer. But fundamentals at this time do not warrant the market cap.
That may be the case. I just went through the released 10Q and it reads like a horror novel. The company is in dire need of revenue or cash infusion soon. The rosy predictions on here and on Twitter seem to be based on a fantasy unless they know something of significance is going to happen to justify anything over 8 cents. I use 8 cents because that seems to be where options are pegged at. Other than that, this seems to be another buy on the rumor and sell on no news after the conference if not before. It's a classic penny stock play. For the company's sake, I hope they have something material to announce. Otherwise, there are going to be a lot of very unhappy shareholders.
Can you explain why you think it is undervalued where it trades right now and why $10 is justified?
Thanks.
I agree with the fact that there has been no material events to justify the rise in the stock price other than a lot of speculation. With several conferences lined up, one can only hope that the company offers something that it hasn't already to not just keep the gains up to today but build upon them. If the company offers nothing new but rehashes what is already known, the stock will quickly shed its gains just as it did last year in July.
What is interesting is that the stock started to make its run around this time last year. It was trading in the 7 cent range at the time. Will it make the same run again?
That wasn't what I asked but thanks!
I have been eyeing this stock for a while and I have been doing my DD but there are two things that keeps me from actually buying shares yet. Price support and Lympro development. Price support should happen soon based on the news released. But, Is there expectation that the company will finally release Lympro data in full detail in July? The company has been absolutely mum about it.